The exogenous wild-type p14ARF gene induces growth arrest and promotes radiosensitivity in human lung cancer cell lines

Journal of Cancer Research and Clinical Oncology

Volumn 127, Issue 6, 2001, Pages 359-367

  Gao, Nan ^a   Hu, Yi D ^a   Cao, Xiao Y ^a   Zhou, Jue ^a   Cao, Shi L ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Lung cancer cell line; p14ARF; Radiosensitivity; Tumor suppressor gene

Indexed keywords

GENE PRODUCT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CELL CYCLE G1 PHASE; CONTROLLED STUDY; DNA DAMAGE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG CANCER; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOSENSITIVITY; TUMOR SUPPRESSOR GENE;

CELL CYCLE; CELL DIVISION; CELL SURVIVAL; CYCLIN-DEPENDENT KINASE INHIBITOR P16; GENE THERAPY; GENES, P53; GENES, TUMOR SUPPRESSOR; HUMANS; LUNG NEOPLASMS; PROTEINS; RADIATION TOLERANCE; RNA, MESSENGER; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY; TUMOR SUPPRESSOR PROTEIN P14ARF;

EID: 0035015886     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004320000184     Document Type: Article

References (42)

1. Alarcon R, Koumenis C, Geyer RK, Maki CG, Giaccia AJ (1999) Hypoxia induces p53 accumulation through MDM2 down-regulation and inhibition of E6-mediated degradation. Cancer Res 59: 6046-6051
2. Arap W, Nishikawa R, Furnari FB, Cavenee WK, Huang H-JS (1995) Replacement of the p16/CDKN2 gene suppresses human glioma cell growth. Cancer Res 55: 1351-1354
3. Arap W, Knudsen E, Sewell DA, Sidransky D, Wang JY, Huang HS, Cavenee WK (1997) Functional analysis of wild-type and malignant glioma derived CDKN2AAralleles: evidence for an RB-independent growth suppressive pathway. Oncogene 15: 2013-2020
4. Badie B, Goh CS, Klaver J (1999) Combined radiation and p53 gene therapy and malignant glioma cells. Cancer Gene Therapy 6: 155
5. ARF links the tumour suppressors RB and p53. Nature 395: 124-125
6. Chiarugi V, Magnelli L, Cinelli M (1995) Dominant oncogenes, tumor suppressors, and radiosensitivity. Cell Mol Biol Res 41: 161
7. INK4/MTS1 gene transcript expressed in B-cell malignancies. Oncogene 11: 21-29
8. Fan S, El-Deiry WS, Bac I, Freeman J, Jondle D, Bhatia K, Fornace AJ, Magrath I, Kohn KW, O'Connor P (1994) p53 gene mutations are associated with decreased sensitivety of human lymphoma cells to DNA damaging agents. Cancer Res 54: 5824-5830
9. Fu XY, Zhang SW, Ran RQ, Shen ZH, Gu JX, Cao SL (1998) Restoration of the p16 gene is related to increased radiosensitivity of p16-deficient lung adenocarcinoma cell lines. J Cancer Res Clin Oncol 124: 621-626
10. INK4a gene is frequently lost in small cell lung cancer. Cancer Res 58: 3926-3931
11. ARF. Cell 91: 555-558
12. Hamada M, Fujiwara T, Hizuta A, Gochi A, Naonoto Y, Takakura N, Takahashi K, Roth JA, Tanaka N, Orita K (1996) The p53 gene is a potent determinant of chemosensitivity and radiosensitivity in gastric and colorectal cancers. J Cancer Res Clin Oncol 122: 360-365
13. INK4a-N in mouse-lung tumor cells. Oncogene 13: 1885-1891
14. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day RS, Johnson BE, Skolnick MH (1994) A cell cycle regulator potentially involved in genesis of many tumor types. Science 264: 436-440
15. ARF. Cell 91: 649-659
16. Kamijo T, Weber JD, Zambetti G, Zindy F, Roussel MF, Sherr CJ (1998) Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2. Proc Natl Acad Sci USA 95: 8292-8297
17. Kasid U, Pfeifer A, Weichselbaum RR, Kritschilo A, Mark G (1987) The raf oncogene is associated with a radiation-resistant human laryngeal cancer. Science 237: 1039-1041
18. Kazuhiko H, Metzger R, Saloniga D, Danenberg K, Leichamab LP, Fink U, Sendler A, Kelsen D, Schwartz GK, Groshen S, Lenz HJ, Danenberg PV (1997) High frequency of simultaneous loss of p16 and p16Kagene expression in squamous cell carcinoma of the esophagus but not in adenocarcinoma of the esophagus or stomach. Oncogene 15: 1481-1488
19. Koh J, Enders GH, Dynlacht BD, Harlow E (1995) Tumor-derived p16 alleles encoding proteins defective in cell cycle inhibition. Nature 375: 506-510
20. Liggett WH, Sewell DA, Rocco J, Ahrendt SA, Doch W, Sidransky D (1996) p16 and p16p1 are potent growth suppressors of head and neck squamous carcinoma cells in vitro. Cancer Res 56: 4119-4123
21. INK4A transcript. Cancer Res 55: 2995-2997
22. McIlwrath AJ, Wasey PA, Ross GM, Brown R (1994) Cell cycle arrests and radiosensitivity of human tumor cell lines: dependence on wild-type p53 for radiosensitivity. Cancer Res 54: 3718-3722
23. McKenna WG, Iliakis G, Weiss MC, Bernhard EJ, Muschel RJ (1991) Increased G2 delay in radiation-resistant cells obtained by transformation of primary rat embryo cells with the oncogenes H-ras and v-myc. Radiat Res 125: 283-287
24. Medema RH, Herrera RE, Lam F, Weinberg RA (1995) Growth suppression by p16INK4 requires functional retinoblastoma protein. Proc Natl Acad Sci USA 92: 6289-6293
25. Miyakoshi J, Kitagawa K, Yamagishi N, Ohtsu S, Day RS, Takebe H (1997) Increased radiosensitivity of p16 gene-deleted human glioma cells after transfection with wild-type p16 gene. Jpn J Cancer Res 88: 34-38
26. Nagasawa H, Keng P, Harley R (1994) Relationship between gamma-ray-induced G2/M delay and cellular radiosensitivity. Int J Radiat Biol 66: 373
27. O'Connor PM, Jackman J, Jondle D, Bhatia K, Magrath I, Kohn K (1993) Role of the p53 tumor suppressor gene in cell cycle arrest and radiosensitivity of Burkitt's lymphoma cell lines. Cancer Res 53: 4776-4780
28. INK4B/MTS2, and p18 genes in primary and metastatic lung cancer. Cancer Res 55: 1448-1451
29. Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell 92: 713-723
30. Pomp J, Ouwerkerk IJM, Hermans J, Wondergem J, Cornelisse CJ, Leer JW, Schrier P (1996) The influence of the oncogenes NRAS and MYC on the radiation sensitivety of cells of a human melonoma cell line. Radiat Res 146: 374-381
31. Quelle DE, Zindy F, Ashmun RA, Sherr CJ (1995) Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated protein capable of inducing cell cycle arrest. Cell 83: 993-1000
32. Sanchez-Cespedes M, Reed AL, Buta M, Wu L, Westra WH, Herman JG, Yang SC, Jen J, Sidransky D (1999) Inactivation of the INK4A/ARF locus frequently coexists with TP53 mutations in non-small cell lung cancer. Oncogene 18: 5843-5849
33. Serrano M, Hannon GJ, Beach D (1993) A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366: 704-707
34. INK4. Science 267: 249-252
35. INK4A inactivation in non-small cell lung cancer cell lines. Cancer Res 55: 6200-6209
36. Sherr CJ (1994) G1 phase progression: cycling on cue. Cell 79: 551-555
37. Sinclair WK, Morton RA (1966) X-ray sensitivity during the cell generation cycle of cultured Chinese hamster cells. Radiat Res 29: 450-474
38. Stone S, Jiang P, Dayananth P, Tavtigian SV, Katcher H, Parry D, Peters G, Kamb A (1995) Complex structure and regulation of the P16 (MTS1) locus. Cancer Res 55: 2988-2994
39. Terasima R, Tolmach LJ (1963) X-ray sensitivity and DNA synthesis in synchronous populations of Hela cells. Science 140: 490-492
40. Vonlanthen S, Heighway J, Tschan MP, Borner MM, Altermatt HJ, Kappeler A, Tobler A, Fey MF, Thatcher N, Yarbrough WG, Betticher DC (1998) Expression of p16INK4a/p16alpha and p19ARF/p16beta is frequently altered in non-small cell lung cancer and correlates with p53 overexpression. Oncogene 17: 2779-2785
41. Wu Q, Possati L, Montesi M, Gualandi F, Rimessi P, Morelli C, Trabanelli C, Barbanti-Brodanao G (1996) Growth arrest and suppression of tumorigenicity of bladder carcinoma cell lines induced by the p16/CDKN2 gene and other loci on human chromosome 9. Int J Cancer 65: 840-846
42. Zhang Y, Xiong Y, Yarbrough WG (1998) ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell 92: 725-734